<SEC-DOCUMENT>0001628280-23-004552.txt : 20230222
<SEC-HEADER>0001628280-23-004552.hdr.sgml : 20230222
<ACCEPTANCE-DATETIME>20230222160301
ACCESSION NUMBER:		0001628280-23-004552
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230222
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230222
DATE AS OF CHANGE:		20230222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		23653013

	BUSINESS ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sgmo-20230222.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:96264fb2-dea2-4678-9c65-0af82c55f9f5,g:277f1967-5fae-4f8a-912e-67f107c22a06,d:c77fc10328164d9e993af0eed599eead--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgmo-20230222</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i55dfd18bd0244425bbe4385809a184ca_D20230222-20230222" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmM3N2ZjMTAzMjgxNjRkOWU5OTNhZjBlZWQ1OTllZWFkL3NlYzpjNzdmYzEwMzI4MTY0ZDllOTkzYWYwZWVkNTk5ZWVhZF80L2ZyYWc6NDhmZWJmYzcwYWExNDkzMGE2MWUxOGU2ZGIyZWE0YTIvdGFibGU6OGU3MmZlMWE2YTBiNGYzYzg4NzkwMGYzZTBiNmM0Y2MvdGFibGVyYW5nZTo4ZTcyZmUxYTZhMGI0ZjNjODg3OTAwZjNlMGI2YzRjY18yLTEtMS0xLTY1NzY0_14cfded5-db18-4295-9e20-23132557763a">February 22, 2023</ix:nonNumeric><ix:nonNumeric contextRef="i55dfd18bd0244425bbe4385809a184ca_D20230222-20230222" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmM3N2ZjMTAzMjgxNjRkOWU5OTNhZjBlZWQ1OTllZWFkL3NlYzpjNzdmYzEwMzI4MTY0ZDllOTkzYWYwZWVkNTk5ZWVhZF80L2ZyYWc6NDhmZWJmYzcwYWExNDkzMGE2MWUxOGU2ZGIyZWE0YTIvdGFibGU6OGU3MmZlMWE2YTBiNGYzYzg4NzkwMGYzZTBiNm